Please activate JavaScript!
Please install Adobe Flash Player, click here for download

Cloettapreis_2004_Nr_32

64. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H., 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646–650. 65. Spira A.I., Ho D.D., 1995. Effect of different donor cells on human immunodefi- ciency virus type 1 replication and selection in vitro. J. Virol. 69:422–429. 66. Stephens J.C., Reich D.E., Goldstein D.B., Shin H.D., Smith M.W., Carrington M., Winkler C., Huttley G.A., Allikmets R., Schriml L., Gerrard B., Malasky M., Ramos M.D., Morlot S., Tzetis M., Oddoux C., di Giovine F.S., Nasioulas G., Chandler D., Aseev M., Hanson M., Kalaydjieva L., Glavac D., Gasparini P., Dean M., 1998. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet. 62:1507–1515. 67. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J., 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848–853. 68. Telenti A., 2004. The genetic cohorts: facing the new challenges in infectious diseases. The HIV model. Enferm. Infecc. Microbiol. Clin. 22:337–341. 69. Telenti A., Aubert V., Spertini F., 2002. Individualising HIV treatment-pharmacoge- netics and immunogenetics. Lancet 359:722–723. 70. Telenti A., Beckmann J.S., Mallal S., 2003. HLA and HIV: modeling adaptation to moving targets. Pharmacogenomics. J. 3:254–256. 71. Telenti A., Munoz M., Bleiber G., Ledergerber B., Kaufmann D.E., 1999. Heterogeneity of response to antiretroviral therapy. AIDS Rev 1:147–155. 72. Tishkoff S.A., Varkonyi R., Cahinhinan N., Abbes S., Argyropoulos G., Destro-Bisol G., Drousiotou A., Dangerfield B., Lefranc G., Loiselet J., Piro A., Stoneking M., Tagarelli A., Tagarelli G., Touma E.H., Williams S.M., Clark A.G., 2001. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293:455–462. 73. Trachtenberg E., Korber B., Sollars C., Kepler T.B., Hraber P.T., Hayes E., Funkhouser R., Fugate M., Theiler J., HsuY.S., Kunstman K., Wu S., Phair J., Erlich H., Wolinsky S., 2003. Advantage of rare HLA supertype in HIV disease progres- sion. Nat. Med. 9:928–935. 74. Turelli P., Doucas V., Craig E., Mangeat B., Klages N., Evans R., Kalpana G., Trono D., 2001. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7:1245–1254. 31

Seitenübersicht